Cargando…
Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients
BACKGROUND: Lung cancer is one of the most common malignant neoplasms worldwide and has a high mortality rate. To enable individualized therapy regimens, a better understanding of the molecular tumor biology has still to be elucidated. The expression of the cell surface protein CD24 has already been...
Autores principales: | Majores, Michael, Schindler, Anne, Fuchs, Angela, Stein, Johannes, Heukamp, Lukas, Altevogt, Peter, Kristiansen, Glen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647809/ https://www.ncbi.nlm.nih.gov/pubmed/26578846 http://dx.doi.org/10.1186/s12907-015-0019-z |
Ejemplares similares
-
Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.
por: Smith, A., et al.
Publicado: (1989) -
Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
por: Smith, A., et al.
Publicado: (1991) -
Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
por: Wawrzynczak, E. J., et al.
Publicado: (1990) -
DBSCAN-SWA: An Integrated Tool for Rapid Prophage Detection and Annotation
por: Gan, Rui, et al.
Publicado: (2022) -
Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer
por: Fuchs, Angela, et al.
Publicado: (2014)